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Abstract
Alterations in tetraspanin CO-029 expression are associated with the progression and metastasis of cancers in the digestive
system. However, how CO-029 promotes cancer metastasis is still poorly understood. To determine the mechanism, we
silenced CO-029 expression in HT29 colon cancer cells and found that the CO-029 knockdown significantly reduced cell
migratory ability. The diminished cell migration was accompanied by the upregulation of both integrin-dependent cell-
matrix adhesion on laminin and calcium-dependent cell-cell adhesion. The cell surface levels of laminin-binding integrin
a3b1 and fibronectin-integrin a5b1 were increased while the level of CD44 was decreased upon CO-029 silencing. These
changes contribute to the altered cell-matrix adhesion. The deregulated cell-cell adhesion results, at least partially, from
increased activity of cadherins and reduced level of MelCAM. In conclusion, CO-029 functions as a regulator of both cell-
matrix and cell-cell adhesion. During colon cancer progression, CO-029 promotes cancer cell movement by deregulating cell
adhesions.
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Introduction
Colorectal cancer, one of the most common cancers, has high
mortality [1]. Patients with metastasis to distant organs such as
liver and lungs suffer extremely poor prognosis. Therefore,
understanding the cellular and molecular mechanisms of colorec-
tal cancer progression is critical for developing new strategies to
improve the prognosis and survival rates for colorectal cancer
patients.
Tetraspanins regulate a variety of physiological and patho-
logical processes, and some tetraspanins are associated with
cancer progression and metastasis [2–11]. Human tetraspanin
CO-029 and its rat homologue, D6.1A, were initially reported
as a tumor-associated antigen expressed in gastric, colorectal,
and pancreatic cancer cells and exert tumor progression-
promoting activity [12]. CO-029 expression is frequently
upregulated in hepatocellular carcinoma [13]. The expression
level of D6.1A is markedly increased, relative to the one in a
differentiated parental line, in a dedifferentiated rat hepatoma
cell line [14]. The simultaneous expression of integrin a6b4 and
D6.1A in nonmetastasizing rat pancreatic adenocarcinoma cell
line BSp73AS facilitates the liver metastasis of this line [15].
CO-029 also exhibits a higher expression level in metastatic
colon carcinoma cells, compared with the level in primary colon
cancer cells [16]. A possible mechanism for the prometastatic
activity of CO-029 is its association with integrins or
tetraspanins, both of which affect cell motility. D6.1A is
associated with integrins a3b1, a6b1, and a6b4 after protein
kinase C (PKC) activation [15,17]. In metastatic pancreatic and
colorectal carcinoma cell lines, the activation of PKC enhances
the colocalization of CO-029 and tetraspanin CD151 with
integrin a6b4 in tumor cells, promotes the internalization of this
integrin-tetraspanin complex, decreases cell-matrix adhesion on
laminin 332, and increases cell migration [18]. Furthermore,
D6.1A-overexpressing tumor cells release the exosomes that
contain D6.1A, and these exosomes induce angiogenesis to
facilitate tumor dissemination [19]. A recent study showed that
E-cadherin and p120-catenin antagonize CO-029 promoted
migration of Isreco colon cancer cells [20]. These studies
strongly suggest an important role for CO-029 in the
progression and metastasis of tumors in the digestive system.
To determine the mechanism by which CO-029 promotes
tumor progression and metastasis, we silenced the expression of
CO-029 in HT29 human colon adenocarcinoma cells. By
combining in vitro and in vivo experiments, we found that the
loss of CO-029 significantly attenuated cell motility and altered
the balance of cell-cell and cell-matrix adhesions, leading to the
decreased metastatic potential of tumor cells.
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Cell Culture, Antibodies, Extracellular Matrix Proteins, and
Other Reagents
HT29 human colorectal adenocarcinoma cell line was obtained
from ATCC (Manassas, VA) and cultured in DMEM supple-
mented with 10% fetal bovine serum, 100 units/ml penicillin, and
100 mg/ml streptomycin.
The antibodies used in this study were intergrin a1 mAb TS2/
7, intergrin a2 mAb IIE10, intergrin a3 mAb A3X8, intergrin a5
mAb BIIG2, intergin a6 mAb A6BB, intergrin b1 mAb TS2/16,
intergrin b4 mAb 439-9B (BD Pharmingen, San Diego, CA), CD9
mAbs C9BB [21] and Mab7, CD63 mAb 6H1 [22], CD81 mAb
M38, CD82 mAb M104, CD151 mAbs 5C11 and TS151r [23],
CO29 mAb NS1116 (kindly provided by Dr. Dorothee Herlyn of
the Wistar Institute), E-cadherin mAb (Santa Cruz Biotechnology,
Santa Cruz, CA), EpCam mAb VU1D9 (Cell Signaling, Danvers,
MA), EWI2 mAb 5E8 (kindly provided by Dr. T. Schweighoffer of
the Novartis Institute for Biomedical Research), and MelCam
mAb P1H12 (Santa Cruz Biotechnology, Santa Cruz, CA). A
mouse IgG2b was used as a negative control antibody (Sigma,
Saint Louis, MO). The second antibodies used in this study were
horseradish peroxidase-conjugated goat-anti-mouse IgG antibody
(Sigma, Saint Louis, MO) and fluorescein isothiocyanate-conju-
gated goat-anti-mouse or -rat IgG antibody (Biosource Interna-
tional, Camarillo, CA).
The extracellular matrix proteins were reconstituted mouse
basement membrane Matrigel (BD Biosciences, Mountain View,
CA), mouse laminin 111 (Invitrogen, San Diego, CA), and human
plasma fibronectin (Invitrogen, San Diego, CA). Other reagents
were from Sigma if the source is not specified.
RNA Interference and Retrovirus Preparation and
Transduction
The CO-029 small hairpin RNA (shRNA) (TGCTGTTGA-
CAGTGAGCGATGAATGAAACTCTCTATGAAATAGT-
GAAGCCACAGATGTATTTCATAGAGAGTTTCATT-
CACTGCCTACTGCCTCGGA), which targets the
TGAATGAAACTCTCTATGAA sequence of human CO-029
mRNA, and control shRNA (RHS1703) were obtained from
OpenBiosystems (Huntsville, AL). Another CO-029 shRNA that
targets a different part of CO-029 mRNA sequence was obtained
from OpenBiosystems (Materials & Methods S1). The vesicular
stomatitis virus (VSV)-G protein expression vector pVSV-G
(kindly provide by Dr. C. Stipp, University of Iowa) and shRNA
were transduced into the GP293 packaging cells by Lipofectamine
2000 (Invitrogen, San Diego, CA). After 48 h, the virus particle-
containing culture supernatant was harvested, and the cell debris
was removed by passing the supernatant through a 0.45-mmol/L
syringe filter. The purified viral stock was incubated with HT29
cells for transduction, and the HT29 cells transduced with control
or CO-029 shRNA were selected with puromycin. The puromy-
cin-resistant cells in CO-029 shRNA transductant were sorted by
flow cytometry to enrich the CO-029-silenced cell population.
Flow Cytometry
Cells were detached with 0.5% trypsin-EDTA, washed with
phosphate-buffered saline (PBS) twice, blocked with 5% goat
serum in DMEM at 4uC for 1 h, incubated with primary mAb,
and then stained with FITC-conjugated goat-anti-mouse IgG at
4uC for 1 h. Stained cells were analyzed on a FACScan flow
cytometer (BD Biosciences).
Immunofluorescence
Cells were fixed with 3% paraformaldehyde at room temper-
ature (RT) for 15 min, permeabilized with 0.1% Brij 98 at RT for
2–5 min, blocked with 20% goat serum at 4uC for 1 h, and
incubated with primary mAbs at 4uC for 1 h, followed by staining
with a secondary antibody at 4uC for 1 h. After each antibody
incubation, the cells were washed three times with PBS. For
immunofluorescent analysis, the cells were examined with an
Axiophot fluorescent microscope (Carl Zeiss, Thornwood, NY),
and images were captured using an Optronics digital camera.
Immunoprecipitation and Western Blot
Immunoprecipitations were carried out as described previously
[24]. Cells were lysed with 1% Nonidet P-40 lysis buffer at 4uC for
1 h. In some experiments, the cell surface was labeled with
0.5 mg/ml EZlink sulfo-NHS-LC biotin (Pierce) before cell lysis.
After removing the insoluble material by centrifugation at
14,0006g and two runs of pre-clearance, lysates were incubated
with primary mAb-absorbed protein A- and G-Sepharose beads
(Amersham Biosciences, Piscataway, NJ) from 3 h to overnight at
4uC. The immunoprecipitates were washed with lysis buffer three
times, dissolved in Laemmli sample buffer, heated at 95uC for
5 min, separated by SDS-PAGE, and then electrically transferred
to nitrocellulose membranes (Bio-Rad, Hercules, CA). The
membranes were sequentially blotted with primary Ab and
horseradish peroxidase-conjugated second Ab (Sigma) for immu-
noblot experiments or horseradish peroxidase-conjugated extra-
vidin (Sigma) for biotinylation experiments, followed by chemilu-
minescence (PerkinElmer Life Sciences, Waltham, MA).
Cell Adhesion Assays
Cell-matrix adhesion assay was performed as described in our
earlier study [25]. Briefly, 96-well microculture plates (BD
Bioscience) were coated with mouse laminin 111 or fibronectin
at 4uC overnight and then blocked with 1% heat-inactivated
bovine serum albumin (Sigma) at 37uC for 1 h. Laminin 332 was
prepared by culturing RAC-11P cells at confluence in the 96-well
plates for 3 days as described earlier [26]. Cells were trypsinized
and suspended in serum-free DMEM medium at a density of
1610
4 cells/ml, and 0.1 ml of the cell suspension was then added
to each well. After incubation for 1 h at 37uC, unattached cells
were removed by rinsing four times with PBS. The attached cells
were visually counted.
Cell-cell adhesion was examined by using the hanging-drop
aggregation assay as described earlier [27]. Cells were detached
with 0.5% tripsin-EDTA and washed with PBS twice, then
rendered into single-cell suspension by three gentle passes through
a 27-gauge needle. The single-cell suspension of 1610
4 cells in
30 ml of solution was suspended as a hanging drop from the lid of a
24-well culture dish and allowed to aggregate overnight at 37
oCi n
5% CO2 with humidity. Complete DMEM was used for
measuring total cell-cell adhesiveness, while calcium-free DMEM
was for calcium-independent cell-cell adhesiveness. To assay the
resistance of cell-cell adhesion to mechanical stress, the cells were
subjected to shear force by passing them through a 200-ml pipet tip
10 times. Calcium-independent cell-cell adhesion was also mea-
sured under relatively mild mechanical stress [28]. Briefly, after
washing with Puck’s saline (5 mM KCl, 140 mM NaCl, 8 mM
NaHCO3, pH 7.4), the single-cell suspension (1610
5 cells/ml) was
incubated in 5% CO2 at 37uC overnight with agitation at 80 rpm
on an orbital shaker. Cells were photographed either before or
after mechanical stress. Cell-cell adhesiveness after shear stress was
quantified as i) the percentage of aggregated cells and/or ii) the
area covered by aggregates. Based on the count of single cells, the
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% aggregation = [1– (number of single cells/number of total
cells)] 6100. The surface area covered by the aggregates was
measured by using ImageJ software to portray the degree of cell
aggregation. Cell aggregate is defined as a cell clump containing
four or more cells.
Cell Migration Assays
Wound healing assay was performed as described in our earlier
study [29]. Briefly, cells were seeded into individual wells of a 24-
well culture plate. When the cells reached confluence, a cell
monolayer was first treated with 10 mg/ml mitomycin C for
30 min to block mitosis and thus allow analysis of cell migration in
the absence of cell proliferation. Then the cell monolayer was
wounded with a sterile, 200- ml pipette tip. The medium and cell
debris were removed and replenished by 2 ml of fresh medium.
Cells were photographed by phase-contrast microscopy every 24 h
after wounding. To evaluate ‘‘wound closure’’, five areas along the
wound were randomly chosen for calculating the average width for
each well. Photos were taken at different time points by an
Olympus inverted-phase contrast microscope.
Transwell cell migration assay was performed as described in
our earlier study [30]. Briefly, the 8-mm pore size, 24-well
Transwell inserts (BD Bioscience, Bedford, MA) were precoated
with 10 mg/ml of laminin 111 or fibronectin onto the underside of
the inserts at 4uC overnight and blocked with 0.1% heat-
inactivated bovine serum albumin (BSA) at 37uC for 1 h. A total
of 2610
4 cells in serum-free DMEM containing 0.1% heat-
inactivated BSA in a volume of 300 ml was added to the upper
chamber, and 500 ml DMEM containing 1% FBS were added to
the lower chamber. The cells in transwells were incubated for 24 h
at 37uC. The cells remaining on the upper surface of the inserts
were removed by wiping with a cotton swab, and the cells that
transmigrated through the pores were fixed and stained with Diff-
Quik Stain Kit (Dade Behring, Inc., Newark, DE). Migration was
quantified by counting the cells on the lower surface of the insert.
Statistical Analyses
All experiments were performed at least four times. Data are
presented as mean6SD. Statistical analysis was performed by
Student’s t-test, and P,.05 was considered statistically significant.
Results
The Silence of CO-029 Expression in HT29 Colon Cancer
Cells
To determine the mechanistic roles of tetraspanin CO-029 in
tumor progression, we established a stable transductant in HT29
human colon adenocarcinoma cells [31], in which CO-029
expression was knocked down by shRNA. The silencing effects
on the total cellular and cell surface CO-029 protein expression
were assessed by using Western blot and flow cytometry,
respectively (Figure 1). Compared with the transductant expressing
control or nonsilencing (NS) shRNA, the transductant expressing
CO-029 shRNA (KD) exhibited a substantial reduction of CO-029
expression at the cell surface (Figure 1A), ranging from approx-
imately 60% to 90%, depending on the cell confluence status in
each individual experiment, and a large loss of total cellular CO-
029 proteins (Figure 1B), typically approximately 90%. The silence
resulting from CO-029 shRNA was specific to CO-029 because
the expression of many other surface proteins, especially other
members of the tetraspanin superfamily, was not reduced (see
following).
The Silence of CO-029 Expression Impaired Migration of
HT29 Cells
We first assessed the effect of CO-029 silencing on cancer cell
migration. To compare the cell migratory ability of NS and KD
transductants, we performed 1) wound healing assay to analyze
collective cell migration, i.e., cell-cell adhesion-dependent cell
migration, and 2) transwell migration assay to analyze solitary cell
migration, i.e., cell-cell adhesion-independent cell migration. In
the wound healing experiments, the repopulation rate or healing
process of the wounded monolayer was markedly reduced in CO-
029 KD transductant cells, and such reduction lasted several days
(Figure 2A and Figure S1A). The reduced wound healing was not
resulted from slower cell proliferation of the KD cells because the
experiments were performed in the presence of mitomycin. The
impaired ability of KD cells in cell migration could also be
observed in the transwell migration assay. Cell migration through
the pored membrane filter onto extracellular matrix proteins such
as laminin 111 and fibronectin was significantly decreased upon
the silencing of CO-029 expression (Figure 2B and Figure S1B).
These results indicate that the silence of CO-029 attenuates the
general ability of cell migration and that the expression of CO-029
is required for strong or robust cell migration.
Figure 1. Silencing CO-029 expression. The CO-029 shRNA and
nonsilencing shRNA were stably expressed in HT29 cells. (A) Flow
cytometric analysis of CO-029 expression at the surface of HT29 cells
that were transfected with nonsilencing (NS) or CO-029 shRNA (KD)
constructs. The negative control mAb was murine IgG, and CO-029 mAb
was NS1116. Mean fluorescent intensity (MFI) of CO-029 on KD cells was
62% less compared to that on NS cells. (B) Western blot analysis of CO-
029 proteins in NS and KD HT29 cells. KD cells displayed a 90% of
reduction in CO-029 proteins. b-actin: loading control.
doi:10.1371/journal.pone.0038464.g001
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invasion is an important parameter to measure cell motility
through 3-dimensional (3D) microenvironment for invasive and
metastatic cancer cells. Cellular invasiveness was measured by the
ability of HT29 transductant cells to invade through Matrigel, a
3D matrix similar to basement membrane, or type I collagen gel, a
3D matrix similar to connective tissue. We found no significant
invasion of either group of HT29-KD cells through either of these
3D matrix environments (data not shown), suggesting that HT29
cells are not invasive, at least in this invasion assay and under the in
vitro test condition.
CO-029 Regulated Cell-matrix and Cell-cell Adhesion
Tumor cell-matrix and cell-cell adhesions are considered to be
the key events that regulate the metastatic cascade [32–34]. To
evaluate the effect of CO-029 silencing on cell-matrix adhesion,
we analyzed and compared the cell-matrix adhesiveness of KD
and NS transductants on laminin and fibronectin. As shown in
Figure 3A, HT29-NS and -KD cells displayed different adhesion
abilities. The KD cells exhibited increased adhesiveness on
extracellular matrix proteins laminin 111 and laminin 332,
suggesting that CO-029 restrains cell adhesion on basement
membrane, which is the matrix environment enriched in
laminins. The cell adhesion on fibronectin, however, exhibited
no differences between NS and KD cells (Figure 3A). We also
examined cell adhesion on hyaluronan, a major proteoglycan of
extracellular environment and the ligand of CD44, because of
the decreased CD44 expression at the surface of HT29-KD cells.
However, HT29 cells appeared not to adhere to hyaluronan,
although an established protocol was followed for this assay [35].
To evaluate the effect of CO-029 silencing on cell-cell
adhesion, we performed cell aggregation assay. First, we
examined cell aggregation in the presence of Ca
++ [28], which
reflects the total cell-cell adhesiveness including both cadherin-
dependent and -independent cell-cell adhesiveness. Silencing
CO-029 resulted in increased ability to form the cell aggregates
that are resistant to relatively strong mechanical stress, compared
with NS cells (Figure 3B). Then, we examined cell-cell
aggregation in the absence of Ca
++, which reflects cadherin-
independent cell-cell adhesiveness such as the one mediated by
IgSF proteins. Ca
++-independent cell-cell adhesion showed no
difference after relatively strong mechanical stress was applied
but was downregulated in KD cells after relatively mild
mechanical force was applied (Figure 3B). In HT29 cells,
Ca
++-dependent cell-cell adhesion makes a major contribution
to total cell-cell adhesion, based on the comparison between the
magnitude of Ca
++-dependent and -independent aggregates after
strong mechanical stress treatment (Figure 3B). Together, CO-
029 confines total and Ca
++-dependent cell-cell adhesion.
CO-029 Silencing Altered Cell Surface Expression Profile
of Adhesion Molecules
The changes in the surface expression of tetraspanins, integrins,
and cell adhesion proteins are involved in tumor progression and
metastasis [17,36–42]. To determine the mechanism by which
CO-029 regulates cell-cell and -matrix adhesions, we measured
and compared the expression levels of cell adhesion proteins on
the surface of HT29-NS and -KD cells. For cell-matrix adhesion
proteins, laminin receptor integrin a3 and fibronectin receptor
integrin a5 were upregulated after silencing CO-029. Integrins b1,
b4, a1, a2, and a6 remained unchanged, while hyaluronan
receptor CD44 was markedly downregulated at the cell surface
(Figure 4A). To determine whether CO-029 silencing affects
integrin activation, we measured and compared the steady state
levels of active b1 integrins in HT29-NS and -KD cells with flow
cytometry by using b1 integrin mAb AG89. The b1 integrin mAb
AG89 recognizes only the b1 integrins in active state [43].
Although the level of active b1 integrins was significantly increased
at the cell surface of HT29-KD cells (Figure 4B left histogram), it
remained unchanged after being calibrated with the level of total
b1 integrins at the cell surface (Figure 4B right histogram). For
cell-cell adhesion molecules, the level of E-cadherin proteins was
not altered on the cell surface (Figure 4C). We also examined other
cell-cell adhesion molecules related to CO-029 and/or tetra-
spanins such as EpCAM, MelCAM, and EWI2, which take part in
Ca
++-independent cell-cell adhesion and some of which belong to
IgSF. Only MelCAM was markedly downregulated at the cell
surface (Figure 4C). Tetraspanins CD9, CD63, CD81, CD82, and
CD151 exhibited no significant alteration at the cell surface upon
CO-029 silencing (Figure 4D).
CO-029 and the Formation of Focal Adhesion, Stress
Fiber, and Adherens Junction
To further evaluate the effect of CO-029 silencing on cell
adhesion, we examined focal adhesion and adherens junction of
the HT29 transfectant cells by staining i) vinculin, a marker of
focal adhesion, and ii) E-cadherin and b-catenin, markers of
adherens junction, respectively. We found that CO-029 silencing
Figure 2. CO-029 silencing impaired colorectal cancer cell
migration. (A) Wound healing assay. Compared with NS cells, wound
closure was significantly impaired in the KD cells at 72 h after creation
of wounds in confluent cell monolayers. (B) Transwell migration assay.
The KD cells displayed impaired motility in transwell migration
experiments. Data are displayed as mean6SD, n=4. *P,.05.
doi:10.1371/journal.pone.0038464.g002
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Figure 5A. Meanwhile, the stress fiber formation near the basal
surface of HT29-KD cells also became less robust compared with
the one in HT29-NS cells (Figure 5A). In contrast, CO-029
silencing appears to have no disruptive effect on the formation of
adherens junction, based on E-cadherin and b-catenin staining
(Figure 5B). The cortical meshwork of actin along lateral surface or
adherens junction exhibited no marked difference between NS
and KD transfectant cells (data not shown).
The Effect of CO-029 Silencing on the Formation of
Tetraspanin-enriched Microdomain (TEM)
Since CO-029 associates with tetraspanins such as CD9 and
CD151 and laminin-binding integrins [11], we examined the effect
of CO-029 silencing on the stability of TEM. The associations of
CD151 with laminin-binding integrins a3b1, a6b1, and a6b4
remained stable under a stringent lysis condition, i.e., 1% Triton
X100-mediated cell lysis, while the associations of CD151 with
other tetraspanins remained stable under only a relatively mild
lysis condition, i.e., 1% Brij 97-mediated cell lysis [3]. CO-029
silencing did not affect the immunoprecipitation profiles of CD151
under either lysis condition (Figure 6A). More laminin-binding
integrins were co-precipitated with CD151 under the 1% NP40
lysis condition upon CO-029 silencing. Both CD151 and CD9
associated with CO-029 under the 1% Brij 97 lysis condition, as
revealed by CD151 and CD9 immunoprecipitation profiles, while
such associations were disrupted under 1% Triton X100 lysis
condition, as expected. Under the 1% Brij 97 lysis condition, CO-
029 immunoprecipitates also revealed CD9-CO-029 association
but no CD151-CO-029 association because of less biotinylation of
CD151 and co-migration of CD151 with CO-029 (Figure 6A).
Figure 3. CO-029 regulated cell-matrix and cell-cell adhesions. (A) Cell-matrix adhesion. Adhesion onto laminin 111, laminin 332, and
fibronectin of HT29-NS and -KD cells was assayed after incubating at 37
oCi n5 %C O 2 for 1 h. The adhesion of the KD cells on laminin 111 and laminin
332 was significantly increased compared with NS cells (P=.042 on laminin 111 and =.048 on laminin 332). (B) Total cell-cell adhesion. Cell
aggregation was measured in the Ca
++-containing media after a relatively strong mechanical force was applied. (C)C a
++-independent cell-cell
adhesion. Cell aggregation was measured in the Ca
++-free media after relatively strong or mild mechanical forces were applied, respectively. The
aggregation of NS and KD cells after shear stress were quantified as described in Materials and Methods. P values are 0.03 for the aggregated cells in
the presence of Ca
++, 0.001 for the area of aggregates in the presence of Ca
++, and 0.0004 for mild stress in the absence of Ca
++. Images of cell
aggregates after the shear-stress treatment were obtained under phase-contrast microscopy. All of the data are projected as mean6SEM (n=4).
*P,.05, **P,.01.
doi:10.1371/journal.pone.0038464.g003
Figure 4. CO-029 silencing altered the surface expression of cell adhesion proteins and tetraspanins. The expression levels of cell-matrix
adhesion proteins (A), active b1 integrins (B), cell-cell adhesion proteins (C), and tetraspanins (D) at the surface of HT29-NS and -KD transfectant cells
were measured by flow cytometry. The relative levels of these proteins on KD cells to NS cells are presented as histograms (mean6SD, n=4,8).
*P,.05, **P,.01. In (B), after normalized by the corresponding relative levels of total integrin b1, the levels of active integrin b1 relative to NS cells are
presented in the histogram on the right.
doi:10.1371/journal.pone.0038464.g004
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in a direct protein-protein interaction manner [3]. We analyzed
the level of integrin a3b1-unbound or ‘‘free’’ CD151 proteins,
which are recognized by CD151 mAb TS151r [23]. At the cell
surface, neither the level of free CD151 nor the total CD151-
normalized level of free CD151 was changed upon CO-029
silencing (Figure 6B). Similarly, CD9 proteins at the cell surface
are either homoclustered or associated with TEMs [21]. We found
that neither the level of homoclustered CD9 nor the total CD9-
normalized level of homoclustered CD9 was changed upon CO-
029 silencing (Figure 6B). Together, these observations suggest
that CO-029 is not required for the interaction of CD151 and
CD9 with TEMs.
Discussion
Tetraspanins regulate tumor progression and metastasis. But the
mechanisms remain largely unknown. At the cellular level,
tetraspanins modulate cell adhesion, migration, proliferation,
and fusion. The adhesiveness and motility of tumor cells partially
determine tumor metastatic potential. Hence, at the cellular level,
tetraspanins probably regulate tumor metastasis by modulating the
abilities of tumor cells to adhere and move. At the molecular level,
tetraspanins associate with integrins, IgSF proteins, growth factors
and their receptors, proteases, and intracellular signaling proteins
to form TEM [44–47]. Hence, at the molecular level, tetraspanins
regulate tumor progression and metastasis probably by altering the
functions of the associated proteins [48–51].
The expression of tetraspanin CO-029 is typically linked to poor
prognosis of digestive system cancers [12,16,18,46,52,53], CO-029
is upregulated upon the progression of colorectal, liver, pancreatic,
and esophageal cancers [11,46,54], and the increased expression
of CO-029 promotes the liver or lung metastasis of these cancers
[17,52,53,55]. Tumor cell migration and invasion are indispens-
able for metastasis. The movement of tumor cells is involved in at
least two phases in the metastasis cascade [52]. The first phase is
that tumor cells migrate away from the primary tumor and invade
the circulatory system; the second phase is that tumor cells migrate
out of blood vessels and into target tissues. The reduced cell
movement upon CO-029 silencing indicates that CO-029 is
required for the efficient migration and invasion of colorectal
cancer cells and suggests that CO-029 likely promotes both stages
of tumor metastasis.
CO-029 appears to promote cell movement by altering cell-
matrix and -cell adhesions. It is well established that cell-cell and -
matrix adhesion directly determines cell motility. For example, the
loss or reduction of E-cadherin expression and/or activity in
tumor cells leads to the dispatch of tumor cells from primary
tumor mass [56]. The increased total and Ca
++-dependent cell-cell
adhesion upon CO-029 silencing is consistent with the reduced
motility of HT29-KD cells and also strongly suggests that CO-029
promotes cell movement by reducing cell-cell adhesion. The
enhanced cell-cell adhesion, caused by CO-029 silencing, likely
results from the increased activity of cadherins and/or other
calcium-dependent cell-cell adhesion molecules. E-cadherin,
however, appears to be unaltered because the cell surface level
of E-cadherin and the recruitment of E-cadherin to adherens
junction remain unchanged. In collective cell migration such as
wound healing, cell-cell adhesion directly regulates cell migration;
and increased calcium-dependent cell-cell adhesiveness upon CO-
029 silencing is likely to be responsible for or at least contribute to
the decreased collective migration or healing process of HT29-KD
cells. While in solitary cell migration such as transwell cell
migration, the increased surface presence of integrins a3b1 and
a5b1 and upregulated activity of integrins a6b1 and/or a6b4
probably cause decreased migration onto extracellular matrices of
HT29-KD cells.
For cell-matrix adhesion, the selectively increased adhesion on
laminins but not on fibronectin upon CO-029 silencing suggests
that CO-029 likely inhibits cell adhesion on laminins. Because
laminins are the constituents of basement membranes that
typically keep epithelial and endothelial cells in stationary, the
role of CO-029 in inhibiting cell adhesion on laminins is consistent
with its role in facilitating cell movement. The increased adhesion
on laminin 111, which is ubiquitously expressed in epithelia,
implies the activation of its receptors of integrins a6b1 and/or
a6b4 because the surface levels of these integrins were not altered
in HT29-KD cells, while increased adhesion on laminin 332,
which is found mainly in skin, intestine, respiratory, and urinary
epithelia, likely reflects the enhanced surface level of its receptor
integrin a3b1, which is the major component of TEMs, and
probably also the enhanced activity of its receptor integrin a6b4.
Although the level of fibronectin-binding integrin a5b1 at the cell
surface is upregulated upon CO-029 silencing, cell adhesion on
fibronectin was not altered in HT29-KD cells, which is
presumably due to a reduced functional activity of integrin a5 b
1 or lower levels and/or activities of other fibronectin-binding
integrins like aV integrins. The altered levels of cell adhesion
proteins at the cell surface upon CO-029 silencing could result
from the altered endocytosis and/or recycling of these transmem-
brane proteins. In other words, CO-029 probably regulates the
trafficking of these proteins through TEMs.
Since the levels of a6 integrins remain unaltered upon CO-029
silencing, the increased cell adhesion onto laminins observed in
our study could result from the upregulated activity of integrin
a6b4. Because HT-29 colon cancer cells form hemidesmosomes
[57,58] and integrin a6b4 is the only integrin in hemidesmosomes,
the upregulated activity of integrin a6b4 may lead to the
formation of stronger or more hemidesmosomes. In addition to
the cell-matrix adhesive structures that can be visualized
microscopically such as focal adhesions and hemidesmosomes,
cell-matrix adhesion is also mediated by the direct engagement to
matrices of the cell adhesion molecules that do not form
microscopic adhesive structure. This type of cell-matrix adhesion
mechanism is diffusely and evenly distributed at the interface of
the basal plasma membrane of a cell and the underlying matrices,
while focal adhesions and hemidesmosomes are spotted at this
interface. Hence, the increased adhesiveness onto laminins could
also reflect the upregulation in level or activity of the laminin-
binding integrins a3b1, a6b1, and a6b4 that do not form
microscopic adhesive structures.
Reduced cell adhesion at the early stage of metastasis helps
release tumor cells from the primary tumor. Cell-cell adhesion
needs to be disrupted so that invasive tumor cells can dissociate
from the primary tumor and infiltrate interstitial tissue. Thus, cell-
Figure 5. The effects of CO-029 silencing on the formations of focal adhesion, stress fiber, and adherens junction HT29 transfectants
were plated on glass coverslips and cultured in complete media for 2 days (for vinculin and F-actin staining, A) or until confluence (for E-cadherin and
b-catenin staining, B). The cells were fixed, permeabilized, and incubated with primary mAbs at 4uC overnight, followed by Alex Fluor 594-conjugated
secondary Ab staining. F-actin was stained by Alex Fluor 594-conjugated phalloidin. The images were captured with confocal microscopy. Bar
=20mm.
doi:10.1371/journal.pone.0038464.g005
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metastasis [59–61]. In addition, tumor cells need to reduce the
adhesiveness on laminins to effectively breach or pass through
various epithelium and endothelium basement membranes that
tumor cells encounter during metastasis. Therefore, we extrapolate
that CO-029 likely facilitates 1) the dispatch of tumor cells by
reducing cell-cell adhesion at the early stage of metastasis, and 2)
the infiltration, intravasation, and extravasation of tumor cells by
confining the adhesion on laminins in the basement membranes of
epithelium and endothelium. Moreover, CO-029 perturbs other
molecules, such as CD44 and MelCAM, important for metastasis.
Besides directly engaging cell-matrix and -cell adhesions, CD44
facilitates cancer progression and serves as a marker for cancer-
initiating cells [62–66]. CD44 could be one of the key molecules
through which CO-029 promotes cell motility and cancer
metastasis, especially given that CO-029 and CD44 form a
complex in colorectal cancer cells and correlate with the
progression of this cancer [9].
In summary, the cell migration capability is markedly dimin-
ished upon the silencing of CO-029. Because CO-029 regulates
cell-cell and cell-matrix adhesions, the reduced motility of HT29-
KD cells likely results from the deregulated cell adhesions. The
altered cell-matrix adhesion is caused by the altered surface
expression or activity of integrins and CD44, while the altered cell-
cell adhesion is caused mainly by the malfunction of calcium-
dependent cell-cell adhesion molecules (Figure S2). Hence, CO-
029 likely promotes the progression and metastasis of colorectal
cancer by enhancing tumor cell movement and deregulating cell
adhesions.
Supporting Information
Figure S1 CO-029 silencing impaired colorectal cancer
cell migration. (A) Wound healing assay. Compared with
HT29-NS transfectant cells, wound closure was significantly
impaired in HT29-KD2 transfectant cells at 72 h after wounds
were generated in confluent cell monolayers. (B) Transwell
migration assay. The KD2 transfectant cells exhibited reduced
motility in Transwell migration experiments. n=3. *P,.05.
(TIF)
Figure S2 Schematic representation of the effect of CO-
029 silencing on cell adhesion proteins.
(TIF)
Materials & Methods S1 Supplemental Materials and
Methods.
(DOC)
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